$NRSN

$2.37 +$0.04 (1.72%) Close

$NRSN Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 1.9M shares outstanding

Who owns NRSN?

By type of holder

Institutions 29.6% Insiders 0.0% Everyone else 70.4%

Concentration Top 10 holders own 28.4%

UBS Group AG 5.8% · Empery Asset Management, LP 5.3%

Institutional ownership

29.6%

+0.9 pts vs last qtr

Institutional holders

-1 vs last qtr

Net shares bought

+17.6K

by institutions in Q2 2026

New / sold out

2 / 3

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

UBS Group AG +59.5K
Independent Advisor Alliance +50.0K

Biggest sellers in Q2 2026

Two Sigma Investments, LP SOLD OUT −44.4K
Meitav Investment House LTD SOLD OUT −40.0K

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Neurosense Therapeutics Ltd in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2022–FY2025

+121.5%

+30.35% a year

Each share's claim on the business

−54.9%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

— vs $5.96M

over 4 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

Institutional shares by how long they've been held

5+ years0% 3–5 years0% 1–3 years27% Under 1 year73%

Quarterly turnover

22.5%

of institutional shares changed hands

Top 10 managers, median time held

2 quarters

Super Investors

Investment managers reporting NRSN on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
UG UBS Group AG	109.8K	5.78%	+59.5K (+118.5%)	2023	0.0%
Shares held by quarter Peak holding109.8K (Q2'26) Change over 8 quarters+109.6K Share of the company5.780% UBS Group AG's full portfolio →
EA Empery Asset Management, LP	100.4K	5.28%	Unchanged	Q4 '25	0.0%
Shares held by quarter Peak holding100.4K (Q4'25) Change over 8 quarters+100.4K Share of the company5.280% Empery Asset Management, LP's full portfolio →

UBS Group AG

109.8K

% of company

5.78%

Change vs last qtr

+59.5K (+118.5%)

Held since

2023

Empery Asset Management, LP

100.4K

% of company

5.28%

Change vs last qtr

Unchanged

Held since

Q4 '25

15 more super investors behind a free account

See every manager holding Neurosense Therapeutics Ltd, how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting NRSN on Form N-PORT; together they hold 0.0% of the company

No fund reports holding NRSN yet.

Comments